Vericel Corporation (United States) is listed on the Nasdaq and has a market capitalization of $3.00 billion, with shareholders equity totaling $384.17 million.
The company employs approximately 398 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Vericel Corporation reported $324.17 million in revenue, generating net income of $33.31 million.
Key financial metrics include a P/E ratio of 90.01, a price-to-book (P/B) ratio of 7.80, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker VCEL.